Weise Andreas, Altmann Friedrich, Rodriguez-Franco Marta, Sjoberg Eric R, Bäumer Wolfgang, Launhardt Heike, Kietzmann Manfred, Gorr Gilbert
Greenovation Biotech GmbH, Bötzingerstr. 29b, D-79111 Freiburg, Germany.
Plant Biotechnol J. 2007 May;5(3):389-401. doi: 10.1111/j.1467-7652.2007.00248.x. Epub 2007 Mar 15.
The highly glycosylated peptide hormone erythropoietin (EPO) plays a key role in the regulation of erythrocyte maturation. Currently, marketed EPO is produced by recombinant technology in mammalian cell cultures. The complementary DNA (cDNA) for human EPO (hEPO) was transiently and stably expressed in the moss Physcomitrella patens wild-type and Delta-fuc-t Delta-xyl-t mutant, the latter containing N-glycans lacking the plant-specific, core-bound alpha1,3-fucose and beta1,2-xylose. New expression vectors were designed based on a Physcomitrella ubiquitin gene-derived promoter for the expression of hEPO cDNA. Transient expression in protoplasts was much stronger at 10 than at 20 degrees C. In Western blot analysis, the molecular size of moss-produced recombinant human EPO (rhEPO) was identified to be 30 kDa, and it accumulated in the medium of transiently transformed protoplasts to high levels around 0.5 microg/mL. Transgenic Physcomitrella Delta-fuc-t Delta-xyl-t mutant lines expressing EPO cDNA showed secretion of rhEPO through the cell wall to the culture medium. In 5- and 10-L photobioreactor cultures, secreted rhEPO accumulated to high levels above 250 microg/g dry weight of moss material after 6 days. Silver staining of rhEPO on sodium dodecylsulphate-polyacrylamide gel electrophoresis (SDS-PAGE) taken from the bioreactor culture demonstrated a high purity of the over-expressed secreted rhEPO, with a very low background of endogenous moss proteins. Peptide mapping of rhEPO produced by the Physcomitrella Delta-fuc-t Delta-xyl-t mutant indicated correct processing of the plant-derived signal peptide. All three N-glycosylation sites of rhEPO were occupied by complex-type N-glycans completely devoid of the plant-specific core sugar residues fucose and xylose.
高度糖基化的肽激素促红细胞生成素(EPO)在红细胞成熟的调节中起关键作用。目前,市售的EPO是通过重组技术在哺乳动物细胞培养物中生产的。人EPO(hEPO)的互补DNA(cDNA)在苔藓小立碗藓野生型和Delta-fuc-t Delta-xyl-t突变体中进行了瞬时和稳定表达,后者含有的N-聚糖缺乏植物特异性的、核心结合的α1,3-岩藻糖和β1,2-木糖。基于小立碗藓泛素基因衍生的启动子设计了新的表达载体,用于hEPO cDNA的表达。原生质体中的瞬时表达在10℃时比在20℃时要强得多。在蛋白质免疫印迹分析中,苔藓产生的重组人促红细胞生成素(rhEPO)的分子大小被鉴定为30 kDa,并且它在瞬时转化的原生质体培养基中积累到高水平,约为0.5μg/mL。表达EPO cDNA的转基因小立碗藓Delta-fuc-t Delta-xyl-t突变体系显示rhEPO通过细胞壁分泌到培养基中。在5升和10升光生物反应器培养中,6天后分泌的rhEPO积累到高于苔藓材料干重250μg/g的高水平。从生物反应器培养物中取出的十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)上的rhEPO银染显示,过表达分泌的rhEPO纯度高,内源性苔藓蛋白背景非常低。小立碗藓Delta-fuc-t Delta-xyl-t突变体产生的rhEPO的肽图分析表明植物来源的信号肽加工正确。rhEPO的所有三个N-糖基化位点都被完全不含植物特异性核心糖残基岩藻糖和木糖的复合型N-聚糖占据。